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Abstract
Background: The aim of this study was to compare the ability of the systolic and diastolic blood pressure (BP), pulse pressure (PP), frac-
tion PP (PPF) and mean arterial pressure (MAP) to predict progression to diabetes in non-diabetic first-degree relatives (FDRs) of patients 
with type 2 diabetes.
Material and methods: A total of 701 non-diabetic FDRs aged 20-70 in 2003 to 2005 were followed through to 2008 for the occurrence 
of type 2 diabetes mellitus. At baseline and through follow-ups, participants underwent a standard 75 g 2-h oral glucose tolerance test. 
Prediction of progression to type 2 diabetes was assessed using area under the receiver-operating characteristic (ROC) curves based upon 
measurement of PP, MAP, PPF, systolic and diastolic BP.
Results: Diabetes developed in 72 participants (10.3%) during the follow-up period. The incidence of type 2 diabetes was 3.4 per 100 
person years in men and 4.9 in women. Systolic and diastolic BP and MAP were related to diabetes, but PP and PPF were not. Systolic 
and diastolic BP and MAP have similar associations with incident diabetes. Areas under the ROC curves were 0.582 for systolic, 0.589 for 
diastolic, 0.589 for MAP, 0.520 for PP, and 0.468 for PPF.
Conclusion: These results indicate that systolic and diastolic BP are as strong as MAP in predicting progression to diabetes. Increased BP 
may help identify FDRs of patients with type 2 diabetes at high risk for diabetes who are candidates for BP control.
(Pol J Endocrinol 2011; 62 (4): 324–330)
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Streszczenie
Wstęp: Celem badania było porównanie wartości prognostycznej skurczowego i rozkurczowego ciśnienia tętniczego (BP), ciśnienia tętna 
(PP), cząstkowego ciśnienia tętna (PPF)  i średniego ciśnienia tętniczego (MAP) w odniesieniu do rozwoju cukrzycy typu 2 u krewnych 
pierwszego stopnia pacjentów chorujących na tę chorobę. 
Materiał i metody: W latach 2003–2005 włączono do badania 701 niechorujących na cukrzycę krewnych pierwszego stopnia osób chorych 
na cukrzyce typu 2 w wieku 20–70 lat i obserwowano ich do 2008 roku pod kątem rozwoju cukrzycy typu 2. Na początku badania i w ciągu 
okresu obserwacji u uczestników wykonywano standardowy 2-godzinny test doustnego obciążenia 75 g glukozy. Oceniano wartość pola 
pod krzywą ROC dla PP, MAP, PPF, skurczowego i rozkurczowego BP w prognozowaniu rozwoju cukrzycy typu 2.
Wyniki: W okresie obserwacji cukrzyca rozwinęła się u 72 uczestników badania (10,3%). Zapadalność na cukrzycę typu 2 wynosiła 3,4 
na 100 osobolat u mężczyzn i 4,9 u kobiet. Skurczowe i rozkurczowe BP oraz MAP wiązały się z cukrzycą, lecz nie stwierdzono takiego 
związku w przypadku PP i PPF. Odnotowano podobne zależności między skurczowym i rozkurczowym BP oraz MAP a zapadalnością 
na cukrzycę. Pola powierzchni pod krzywymi ROC wynosiły 0,582 dla skurczowego BP, 0,589 dla rozkurczowego BP, 0,589 dla MAP, 0,520 
dla PP i 0,468 dla PPF.
Wnioski: Powyższe dane wskazują, że skurczowe i rozkurczowe BP były równie silnie jak MAP związane z rozwojem cukrzycy. Pod-
wyższone BP może być pomocne w identyfikowaniu krewnych pierwszego stopnia chorych na cukrzycę typu 2 obciążonych wysokim 
ryzykiem zachorowania na cukrzycę, dlatego należy u nich monitorować ciśnienie tętnicze. (Endokrynol Pol 2011; 62 (4): 324–330)
Słowa kluczowe: krewni pierwszego stopnia, ciśnienie tętna, ciśnienie tętnicze, cukrzyca typu 2
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Introduction
Type 2 diabetes mellitus continues to rise in prevalence 
worldwide. Diabetes prevention has become a major 
public health priority in both developed and developing 
nations. Therefore, there is great interest in identifying 
individuals at high risk of developing diabetes. The 
importance of arterial blood pressure (BP) as a predictor 
of type 2 diabetes, and the benefits of treatment, have 
been discussed.
However, BP can be divided into two other com-
ponents: steady (mean arterial pressure or MAP) and 
pulsatile (pulse arterial pressure or PP) [1, 2]. Some stu-
dies have demonstrated that different BP components 
are predictors of type 2 diabetes [3–9].
However, no studies have compared the ability 
of different BP components to predict progression to 
diabetes.
Diabetes mellitus has been associated with an in-
crease in arterial stiffness or a decrease in vascular dis-
tensibility [10–13]. Although it is plausible that diabetes 
mellitus increases PP by increasing arterial stiffness, 
there has been no extensive exploration of the direct 
relationship between PP and progression to diabetes. To 
date, one study has investigated the relationship be-
tween PP and the risk of developing diabetes in high 
risk hypertensive patients. This study postulated that 
the relationship between PP and diabetes could be at-
tributable to increased arterial stiffness [14]. However, 
while Yasuno et al. [14] referred to PP as the independ-
ent risk factor for progression to diabetes in high-risk 
hypertensive patients, it is likely that genetic factors also 
influence risk of progression to diabetes. High BP and 
glucose metabolism risk factors [15–17] such as obesity 
are determined by genetic and early environmental 
influences. The first-degree relatives (FDRs) of patients 
with type 2 diabetes (which has a genetic basis) are at 
high risk of glucose intolerance and might be more ap-
propriate for testing this hypothesis.
The aim of this study therefore was to compare the 
ability of systolic and diastolic BP, PP, fraction PP (PPF), 
and MAP to predict the incidence of type 2 diabetes 
in non-diabetic FDRs of patients with type 2 diabetes.
Material and methods
Participants and data collection
The Isfahan Diabetes Prevention Study (IDPS) is an on-
going cohort study in central Iran to assess the efficacy 
of intensive diet and exercise to prevent or delay the 
onset of type 2 diabetes mellitus in FDRs of patients 
with type 2 diabetes. The study was performed between 
2003 and 2005. 2,368 (614 men and 1,754 women) of 
a consecutive sample of patients with type 2 diabetes 
attending clinics at Isfahan Endocrine and Metabolism 
Research Centre were included in the study. The partici-
pants completed laboratory tests including standard 75 
g 2-hour oral glucose tolerance test (OGTT) and a ques-
tionnaire on their health status and on various potential 
risk factors for diabetes. Participants received follow-up 
tests according to a medical care standard in diabetes 
[18] to update information on demographic, anthropo-
metric, BP, and lifestyle factors and on newly diagnosed 
diabetes. Accordingly, if OGTT was normal at baseline, 
repeat testing was carried out at least every three 
years. Otherwise, repeat testing was carried out annu-
ally. The IDPS baseline methods have been described in 
detail elsewhere [19]. The participants included siblings 
and children. The tenets of the Declaration of Helsinki 
were followed, institutional ethical committee approval 
was granted, and an informed consent form was signed 
by each participant.
Ascertainment of diabetes
Cases of diabetes were identified from baseline and 
follow-up OGTTs according to the criteria of the Ameri-
can Diabetes Association (ADA) [20]. Pregnant women 
were excluded. This study used data from 701 FDRs 
(150 men and 551 women) who were free of diabetes at 
registration, and had at least one subsequent review in 
the mean follow-up period of 2.3 (range 1–4) years. At-
tendees at the follow-up visit did not differ significantly 
from non-attendees regarding most baseline charac-
teristics: age, gender, height, weight, body mass index 
(BMI), waist circumference (WC), hip circumference, 
waist-to-hip ratio (WHR) and levels of fasting plasma 
glucose (FPG), cholesterol, high-density lipoprotein 
(HDL) cholesterol, triglyceride, systolic BP or obesity. 
However, non-attendees had slightly lower diastolic 
BP (73.5 mm Hg versus 74.6 mm Hg, p < 0.05), HbA1c 
(5.0% vs. 5.1%, p < 0.05), and plasma glucose (PG) at 
30 min. (142.2 mg/dl vs. 147.0 mg/dl, p < 0.01), 60 min. 
(145.1 vs. 155.5, p < 0.01) and 120 min. (115.0 mg/dl 
vs. 127.8 mg/dl, p < 0.01), but higher levels of low-den-
sity lipoprotein (LDL) cholesterol (118.5 mg/dl versus 
115.3 mg/dl, p < 0.05).
Covariates of interest collected at baseline and 
through follow-ups included age, gender, body size, 
HbA1c, cholesterol, LDL, HDL, triglyceride and BP, family 
and personal medical history. The same methodology 
was used for both the prevalence and incidence stu-
dies. Participants reported to clinics in the morning after 
an overnight fast. Subjects were asked to abstain from 
vigorous exercise the evening before, and the morning of, 
the investigations. Smokers were encouraged to abstain 
from smoking in the morning of the investigations. 
Firstly, on arrival at the clinic, the information given 
by the participants in the questionnaire as to their 
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family history was verified. Then, with the subjects in 
light clothes and without shoes, height, weight, waist 
and hip circumference were measured using standard 
apparatus. Resting BP was measured using a standard 
mercury column sphygmomanometer, with a cuff of 
appropriate size, in a seated position after subjects had 
been seated for ten minutes by the examining physician. 
The participants were explicitly asked not to cross their 
legs during measurement. FPG was measured using the 
glucose oxidase method. All five subjects underwent 
a standard OGTT (75 g glucose 2-hour) at baseline and 
at the follow-ups. Venous blood was sampled at fasting, 
30, 60, and 120 min. after oral glucose administration. 
Plasma samples obtained after centrifugation were 
analysed the same day.
HbA1c (measured by ion-exchange chromatogra-
phy), total cholesterol, triglyceride, HDL, and LDL 
calculated by the Friedewald equation [21] were also 
assessed. All blood sample procedures were performed 
in the central laboratory of the Isfahan Endocrine and 
Metabolism Research Centre using the enzyme-linked 
method.
Definitions
BMI was measured as the ratio of weight (kg) to squared 
height (m2), the latter being assessed at baseline only. 
Diabetes was defined if: 
 — two times FPG ≥ 126 or;
 — one time 2-hour plasma glucose of  ≥ 200 mg/dl or;
 — self-report of diabetic treatment.
PP was defined as the difference between systolic 
and diastolic blood pressure. MAP was calculated as 
[(2 × diastolic BP) + systolic BP]/3. PPF [22] was calcu-
lated as PP divided by MAP.
Determination of diabetes incidence
Incidence of diabetes was expressed as the number of 
type 2 diabetes cases per 100 person-years of follow-up. 
The relevant period was considered to be the date of 
completion of the baseline examination between 2003 
and 2005 until whichever came first out of:
 — the occurrence of diabetes or
 — the date of the last completed follow-up or
 — death, or
 — the end of the follow-up on 31 December, 2007.
Statistical analysis
Statistical methods used included the Student’s t-test, 
chi squared test, and Cox’s proportional hazards model. 
Different Cox’s proportional hazards models were fit-
ted to estimate the effect of systolic and diastolic BP, PP, 
PPF, and MAP on the risk of new-onset diabetes using 
SPSS for Windows (SPSS Inc., Chicago, IL, USA). Vari-
ables including age, BMI, total cholesterol and BP were 
entered the multiple-adjusted analyses as continuous 
variables, while gender was categorical.
All anthropometric or BP measures were not in-
cluded simultaneously in regression analysis to avoid 
co-linearity that these independent variables may have. 
Adjustment for age and gender was examined in sepa-
rate models. Age-adjusted means were calculated and 
compared using general linear models. The ability of PP, 
PPF, and MAP, systolic and diastolic BP values to predict 
the incidence of diabetes was examined by receiver op-
erating characteristic (ROC) curve and their respective 
areas under the curve (AUC), in which sensitivity was 
plotted as a function of 1-specificity.
Areas under the ROC curves were compared by the 
algorithm developed by DeLong et al. [23]. All tests for 
statistical significance were two-tailed, and performed 
assuming a type I error probability of < 0.05.
Results
The mean (standard deviation or SD) age of patients 
was 42.7 (6.4) years. Patients enrolled had a mean (SD) 
HbA1c of 5.1% (0.8), systolic BP of 115.1 (16.0) mm Hg, 
diastolic BP of 74.6 (12.1) mm Hg, MAP of 88.1 (12.3) 
mm Hg, PP of 40.5 (11.6) mm Hg and PPF of 4.7 (1.3) 
mm Hg at baseline. The prevalence of obesity (BMI ≥ 30) 
was 37.6%.
There was a significant correlation between systolic 
BP and diastolic BP (r = 0.70) and PP (r = 0.66) and 
between systolic BP and MAP (r = 0.88) (p < 0.001). 
The systolic BP and PPF were significantly but weakly 
correlated (r = 0.19, p < 0.001).
During 1,630 (354 men and 1,276 women) per-
son-years of follow-up, 72 (11 men and 61 women) in-
cident cases of type 2 diabetes occurred. The overall in-
cidence of subsequent diabetes was 4.4 (95% CI: 3.5–5.6) 
per 100 person-years. The incidence rate was higher in 
women (4.9, 95% CI: 3.7–6.2 per 100 person-years) than 
men (3.4, 95% CI: 1.8–5.8), but the difference was not 
statistically significant.
Table I shows the group means (SE) and proportions 
for those FDRs who did and did not develop diabe-
tes. Those who developed diabetes had higher systolic 
and diastolic BP, MAP, BMI, WC, hip circumference, FPG, 
plasma glucose at 30, 60 and 120 min., HbA1c, cholesterol, 
LDL and were more obese at baseline.
The incidence of diabetes was 5.6% per year (95% 
CI: 3.4, 8.5) for participants in the highest quartile of 
systolic BP, and 3.3% per year (95% CI: 1.8, 5.4) for the 
lowest quartile. The equivalent incidences for diastolic 
BP were 6.5% (95% CI: 4.0, 9.8) and 3.4% per year (95% 
CI: 2.2, 4.9). For individuals in the highest quartile of PP, 
the incidence of diabetes was 4.2% (95% CI: 2.4, 6.8) and 
for the lowest quartile 3.9% per year (95% CI: 2.3, 6.2). 
327
Endokrynologia Polska/Polish Journal of Endocrinology 2011; 62 (4)
PR
A
C
E 
O
R
Y
G
IN
A
LN
E
The incidence of diabetes was 5.7% (95% CI: 3.6, 8.5) 
for individuals in the highest quartile of MAP, and for 
the lowest quartile 2.6% (95% CI: 1.2, 4.6). The associa-
tion between systolic and diastolic BP and MAP and 
type 2 diabetes was similar and the risk of type 2 dia-
betes increased with increasing quartiles of these three 
BP indicators. In age-adjusted and gender-adjusted 
analysis comparing the associations in the highest to 
the lowest quartile, the MAP relative risk was slightly 
stronger than the systolic or diastolic hazard ratios 
(Table II). Age-, gender-adjusted hazard ratio shows 
diastolic BP and MAP is associated with diabetes only 
in higher quartiles. The associations were attenuated 
after adjustment for body mass index, suggesting it is 
the key intermediate factor in the pathway between BP 
and diabetes (data not shown).
The areas under the ROC curves for incidence of 
type 2 diabetes were 0.582 (95% CI: 0.510–0.654), 0.589 
(95% CI: 0.519–0.660), 0.520 (95% CI: 0.447–0.594), 0.589 
(95% CI: 0.518–0.661) and 0.468 (95% CI: 0.398–0.538) 
for the systolic, diastolic, PP, MAP and PPF respectively 
(Figure 1). Systolic, diastolic and MAP were significant 
predictors for future risk of type 2 diabetes (p < 0.05). 
MAP had an area similar to systolic and diastolic BP.
Discussion
The predictive value of different BP components is 
important because type 2 diabetes mellitus is associated 
with considerably increased risk of cardiovascular 
disease. 
This study shows for the first time that the discrimi-
natory ability of systolic and diastolic BP is as good as 
that of MAP, further emphasising the utility of systolic or 
diastolic BP alone in predicting diabetes. PP is a weaker 
diabetes risk predictor than systolic and diastolic BP and 
MAP. No study has previously compared the association 
between different components of BP and risk of diabetes.
A few studies have so far analysed the relationship 
between BP and incidence of diabetes [3–9].
Table I. Age, age-adjusted means [SE] and proportions of selected baseline characteristics between 72 first-degree relatives of 
patients with type 2 diabetes who did, and 629 who did not, develop diabetes
Tabela I. Wiek, skorygowane wzgledem wieku średnie (SE) i odsetkowe wartości dla wybranych parametrów w grupie 
72 krewnych pierwszego stopnia, u których rozwinęła się cukrzyca i 629 krewnych pierwszego, którzy nie zachorowali na cukrzycę 
Variables Developed diabetes Not developed diabetes Difference (95% CI)
Mean (SE) Mean (SE)
Age [years] 43.6 [0.74] 42.6 [0.25] 1.0 [–0.56, 2.56]
BMI [kg/m2] 30.9 (0.48) 28.9 (0.16) 2.0 (1.11, 3.09)***
Waist circumference [cm] 92.0 (1.04) 88.3 (0.35) 3.7 (1.72, 6.08)**
Hip circumference [cm] 111.7 (1.04) 107.7 (0.35) 4.0 (1.83, 6.17)***
Waist-to-hip ratio 0.82 (0.007) 0.82 (0.003) 0.00 (–0.01, 0.01)
Systolic BP [mm Hg] 119.5 (1.92) 114.6 (0.64) 4.9 (1.33, 9.47)*
Diastolic BP [mm Hg] 78.6 (1.45) 74.2 (0.49) 4.4 (1.58, 7.62)**
Pulse pressure [mm Hg] 41.4 (1.41) 40.4 (0.47) 1.0 (–1.65, 4.25)
Mean arterial pressure [mm Hg] 91.9 (1.49) 87.7 (0.50) 4.2 (1.47, 7.73)**
Fraction pulse pressure [mm Hg] 4.5 (0.17) 4.7 (0.05) –0.2 (–0.53, 0.13)
Baseline fasting glucose [mg/dl] 106.1 (1.35) 93.3 (0.46) 12.8 (10.20, 15.80)***
Plasma glucose 30 min [mg/dl] 168.5 (3.72) 144.7 (1.23) 23.8 (16.9, 32.3)***
Plasma glucose 60 min [mg/dl] 193.8 (4.96) 151.2 (1.65) 42.6 (33.40, 54.20)***
Plasma glucose 120 min [mg/dl] 156.8 (4.11) 124.5 (1.38) 32.3 (24.50, 41.70)***
HbA1c (%) 5.4 (0.12) 5.1 (0.04) 0.3 (0.05, 0.55)*
Triglyceride [mg/dl] 170.9 (12.34) 168.7 (4.19) 2.2 (–22.10, 29.10)
Cholesterol [mg/dl] 202.5 (4.83) 192.5 (1.62) 10.0 (1.01, 21.40)*
HDL cholesterol [mg/dl] 45.2 (1.40) 45.3 (0.48) –0.1 (–3.02, 2.82)
LDL cholesterol [mg/dl] 123.0 [4.25] 114.4 [1.48] 8.6 [0.45, 18.40]*
Men 15.3% 21.7% –6.4 [–15.30, 2.48]
Obesity [BMI ≥ 30] 53.5% 35.7% 17.8 [5.57, 30.00]**
Age-adjusted means were calculated using general linear models. The difference in the mean or percentage o f the variables between diabetes and no 
diabetes. *p < 0.05, **p < 0.01, ***p < 0.001. CI= Confidence interval
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Similar to our findings, the Women’s Health 
Study [3], the Atherosclerosis Risk in Communities 
Study [4], the Netherlands study [5] and the Ger-
man study [6] found that high BP was associated 
with an increased risk of type 2 diabetes. Gress et 
al. [8] found that subjects with hypertension had 
a relative risk of 2.3 of developing type 2 diabetes 
compared to subjects without hypertension. Almgren 
et al. [24] found that treated hypertensive patients 
are at an increased risk of type 2 diabetes, and that 
this is associated with a high risk for cardiovascular 
complications and mortality. One study found that 
the risk of developing type 2 diabetes increases with 
increasing number of metabolic abnormalities, but 
that BP per se was not independently associated with 
new-onset diabetes [7].
On the basis of our overall findings, systolic and 
diastolic BP and MAP have approximately the same 
predictive discrimination. Because systolic and diastolic 
BP is strongly correlated with MAP, they are unlikely 
to yield different answers and the three measures yield 
similar information, with the correlation coefficient 
above 0.80.
The association between PP and risk for diabetes in 
the FDRs of patients with type 2 diabetes has not been 
elucidated. A recent study of the association between 
PP and the incidence of type 2 diabetes in high-risk 
hypertensive patients found PP was an independent 
predictor for new-onset diabetes and postulated that 
the relationship between PP and diabetes could be at-
tributable to increased arterial stiffness [14]. The lack of 
relationship between PP and diabetes risk in the present 
Table II. Incidence rates and relative risks (95% CI) of type 2 diabetes by quartiles of blood pressure parameters, the Isfahan 
Diabetes Prevention Study, 2003–2008
Tabela II. Zapadalność i ryzyko względne (95% CI) zachorowania na cukrzycę typu 2 w zależności od kwartyli wartości 
ciśnienia tętniczego w badaniu Isfahan Diabetes Prevention Study, 2003–2008 
Variables Cases (no.) Incidence/100 
person-year
Age-adjusted hazard 
ratio (95% CI)
Age and gender adjusted 
hazard ratio (95% CI)*
Systolic blood pressure
1st quartile (<  100.5 mm Hg) 14 3.26 1.00 1.00
2nd quartile (100.5–110.0 mm Hg) 11 3.08 0.94 (0.43, 2.08) 0.96 (0.44, 2.13)
3rd quartile (110.1–120.0 mm Hg) 21 5.44 1.59 (0.80, 3.16) 1.64 (0.83, 3.27)
4th quartile (> 121.0 mm Hg) 20 5.56 1.62 (0.81, 3.25) 1.68 (0.83, 3.38)
Diastolic blood pressure
1st quartile (< 70.0 mm Hg) 25 3.36 1.00 1.00
2nd quartile (70.0–75.0 mm Hg) 5 4.38 1.28 (0.79, 3.34) 1.33 (0.51, 3.48)
3rd quartile (75.1–80.0 mm Hg) 18 4.88 1.41 (0.77, 2.59) 1.40 (0.76, 2.58)
4th quartile (> 80.0 mm Hg) 20 6.45 1.86 (1.03, 3.35)* 1.93 (1.07, 3.49)**
Pulse pressure
1st quartile (< 30.0 mm Hg) 17 3.92 1.00 1.00
2nd quartile (30.0–40.0 mm Hg) 26 4.62 1.20 (0.65, 2.22) 1.18 (0.64, 2.17)
3rd quartile (40.1–45.0 mm Hg) 7 4.46 1.12 (0.47, 2.71) 1.17 (0.48, 2.82)
4th quartile (> 45.0 mm Hg) 16 4.23 1.04 (0.52, 2.06) 1.02 (0.79, 3.04)
Mean arterial pressure
1st quartile (< 80.0 mm Hg) 10 2.55 1.00 1.00
2nd quartile (80.0–87.0 mm Hg) 18 4.65 1.78 (0.82, 3.87) 1.82 (0.84, 3.96)
3rd quartile (87.1–94.0 mm Hg) 16 4.36 1.65 (0.74, 3.65) 1.66 (0.75, 3.69)
4th quartile (> 94.0 mm Hg) 22 5.70 2.11 (0.99, 4.50) 2.20 (1.03, 4.71)**
Fraction pulse pressure
1st quartile (< 3.8 mm Hg) 17 3.83 1.00 1.00
2nd quartile (3.8–4.5 mm Hg) 19 5.71 1.46 (0.76, 2.81) 1.44 (0.75, 2.78)
3rd quartile (4.6–5.4 mm Hg) 18 4.64 1.20 (0.62, 2.33) 1.18 (90.61, 2.30)
4th quartile (> 5.4 mm Hg) 12 3.27 0.84 (0.40, 1.77) 0.83 (0.78, 3.02)
*Hazard ratios (with 95% CI) calculated by Cox proportional hazard model; **p <0.001. CI= Confidence interval
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study may be considered somewhat surprising. It is 
probably caused by the increasing importance of arte-
rial stiffness with ageing. The association between age 
and PP is well described [25]. The younger age of our 
sample may explain why PP was not associated with 
diabetes. The significance of PP could be different and 
independent, but apparently is not correlated to the risk 
of diabetes. This awaits further investigation.
The mechanisms whereby high BP exerts negative 
effects on diabetes risk are not entirely clear. A possible 
explanation could be that elevated BP is associated with 
endothelial dysfunction, which is also related to insulin 
resistance and the development of type 2 diabetes [26]. 
On the other hand, elevated BP could be a marker for 
underlying insulin resistance, which constitutes a com-
mon soil for diabetes and cardiovascular disease [27]. 
Furthermore, research has demonstrated that high BP 
levels are accompanied by an elevation of inflammatory 
markers [28], which could also enhance the develop-
ment of type 2 diabetes [29, 30]. Finally, studies have 
shown that pharmacological treatment of hypertension 
could lead to glucose intolerance and at least to the 
manifestation of type 2 diabetes [4, 24]. 
The strengths of our study include the fact that the 
sample consists of both men and women of a wide age 
range, and that the diagnosis of diabetes was based on 
standard OGTT and information on the potential deter-
minants of glucose intolerance. Selection and information 
bias were unlikely because of the prospective design. 
Our study was limited to a cohort of individuals who are 
at increased risk of developing type 2 diabetes, as they 
had FDRs with the disease. This group of individuals 
will only increase further over time as the prevalence 
of diabetes increases worldwide [30]. Even though the 
study included more than 700 participants who were 
thoroughly examined and followed up, the follow-up 
period of two years may be controversial. Due to the 
still conflicting results in assessing diabetes prediction, 
a long-term follow-up (i.e. of 3–6 years) in a large cohort 
could clarify the situation even more. At follow-up, 
non-attendees of the entire population did not differ 
from attendees by major risk factors for progression to 
diabetes, although a difference too small to explain the 
high progression rate to diabetes in our study was seen 
in the mean levels of LDL, HbA1c, and PG. The higher 
risk of developing type 2 diabetes in FDRs with high 
systolic and diastolic BP underlines the importance of 
preventing type 2 diabetes in these individuals. Several 
clinical trials have demonstrated that lifestyle [31–33] and 
pharmaceutical [31] interventions in high-risk individuals 
can prevent the development of diabetes, providing a ra-
tionale for the identification of high-risk subjects so as to 
institute early lifestyle or pharmacological interventions.
In conclusion, our study indicates that the systolic, 
diastolic and MAP are very highly correlated and likely 
to behave similarly in diabetes prediction. Further stu-
dies are needed to better understand the role of different 
BP components to predict diabetes. Increased BP may 
help identify FDRs of patients with type 2 diabetes at 
high risk for diabetes who are candidates for BP control. 
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Figure 1. Receiver operating characteristic curves for systolic 
and diastolic BP, mean arterial pressure (MAP), pulse pressure 
(PP) and fraction PP for predicting type 2 diabetes in non-diabetic 
first-degree relatives of patients with type 2 diabetes. Estimates 
of the areas under the ROC curves and their 95% confidence 
intervals are shown
Rycina 1. Krzywe ROC dla ciśnienia skurczowego i rozkurczowego, 
średniego ciśnienia tętniczego (MAP) i cząstkowego ciśnienia 
tętna (PP) w prognozowaniu rozwoju cukrzycy typu 2 
u krewnych pierwszego stopnia osób chorych na cukrzycę typu 2. 
Przedstawiono pola pod krzywą i 95-procentowe przedziały ufności
Area under the curve (95% CI)
Systolic blood pressure 0.582 (0.510, 0.654)
Diastolic blood pressure 0.589 (0.519, 0.660)
Mean arterial pressure 0.589 (0.518, 0.661)
Pulse pressure 0.520 (0.447, 0.594)
Fraction pulse pressure 0.468 (0.398, 0.538)
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